Mereo BioPharma (MREO) EPS (Basic) (2019 - 2026)
Mereo BioPharma's (MREO) quarterly EPS (Basic) came in at -$0.04 in Q2 2026, up 52.32% year-over-year from -$0.03 in Q2 2025, and down 4.03% quarter-over-quarter from -$0.04 in Q1 2026.
Powered by 
Analysis
Mereo BioPharma (MREO) EPS (Basic) (2019 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported EPS (Basic) for 5 consecutive years, with -$0.04 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 52.32% year-over-year to -$0.04 in Q2 2026; TTM through Jun 2026 was -$0.24, a 36.58% increase from a year earlier, with the FY2025 full-year figure at -$0.33, up 10.34% from the prior year.
- EPS (Basic) was -$0.04 for Q2 2026 at Mereo BioPharma, down from -$0.04 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.01 in Q2 2023 and troughed at -$0.12 in Q4 2024.
- A 4-year average of -$0.07 and a median of -$0.08 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) tumbled 517.93% in 2024 and jumped 54.92% in 2025, its largest moves.
- Over 4 years, EPS (Basic) stood at -$0.07 in 2023, then tumbled by 75.3% to -$0.12 in 2024, then advanced by 7.96% to -$0.11 in 2025, then surged by 60.88% to -$0.04 in 2026.
- The last three EPS (Basic) figures came in at -$0.04 (Q2 2026), -$0.04 (Q1 2026), and -$0.11 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Mereo BioPharma | 38.92 Mn | 38.92 Mn | - | -0.04 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04 |
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.05 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2019 | -1.34 |